MEDICO REMEDIES
Back to Income Statement
|
MEDICO REMEDIES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹151 Cr | ₹145 Cr | ₹140 Cr | ₹121 Cr | ₹122 Cr |
What is the latest Revenue of MEDICO REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹145 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹121 Cr |
| Mar2021 | ₹122 Cr |
How is Revenue of MEDICO REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | 4.15 | |
| Mar2024 | ₹145 Cr | 3.19 | |
| Mar2023 | ₹140 Cr | 16.04 | |
| Mar2022 | ₹121 Cr | -1.12 | |
| Mar2021 | ₹122 Cr | - | |
Compare Revenue of peers of MEDICO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICO REMEDIES | ₹322.0 Cr | -0.6% | -8.1% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
MEDICO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICO REMEDIES | -0.6% |
-8.1% |
-6.2% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses